A frank Q&A with J&J DePuy president on the slow Synthes IntegrationBy Tiger "Timing was right for sale of Synthes" video Michel Orsinger, head of the orthopedics business of Johnson & Johnson […] Get access to full posts, newsletters, trends, and market reports for only subscribe for $1/day. Hit the SUBSCRIBE button at the top of the homepage. Username or E-mail Password Remember Me Forgot Password
The Orthopedics Industry 